Coya Therapeutics, Inc.
COYA
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$4.22
FAIR PRICE
$3.28
MARGIN
$0.94
P/E Ratio
N/A
Div. Yield
N/A
ROE
-64.3%
Market Cap
$70M
Small-cap
COMING SOON
Get notified when COYA's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Arun Swaminathan
COUNTRY
US
HEADQUARTERS
Houston
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate COYA's fair price
Coya Therapeutics, Inc.'s fair price of $3.28 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $4.22, COYA trades 22.3% above its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting COYA's risk profile.
RELATIVE · 30%
Comparing COYA's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for COYA, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for COYA.
Explore on BuliosFAQ
What is the fair price of COYA?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Coya Therapeutics, Inc. is $3.28. At the current market price of $4.22, COYA trades 22.3% above its calculated fair value.
Is COYA overvalued or undervalued?+
Coya Therapeutics, Inc. is currently overvalued based on our valuation model. The stock trades at $4.22, which is 22.3% above the fair price of $3.28.
How often is COYA's fair price updated?+
We update fair price calculations for COYA daily after market close. The current fair price of $3.28 incorporates the latest market data and sector multiples.
What factors affect COYA's fair price calculation?+
COYA's fair price of $3.28 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -64.3%.
Is COYA a good buy right now?+
At $4.22, COYA trades 22.3% above our fair value estimate of $3.28. The stock is currently overvalued. ROE stands at -64.3% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does COYA pay dividends?+
COYA does not currently pay a dividend.